Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-036343
Filing Date
2023-06-12
Accepted
2023-06-12 16:41:33
Documents
2
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6211
2 POA DOCUMENT poa.txt EX-24 2558
  Complete submission text file 0001209191-23-036343.txt   10364
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SALIX PHARMACEUTICALS, LTD. 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615
Business Address
Forbes William P (Reporting) CIK: 0001314760 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 231008696